Heart Defect Closure Device Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Heart Defect Closure Device Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for heart defect closure devices has experienced a swift expansion lately, projected to increase its valuation from $1.11 billion in 2024 to $1.27 billion the following year, reflecting a compound annual growth rate of 13.8%. This upward trajectory during the past period stems from several key factors, including the increasing prevalence of congenital heart conditions among the population, the demographic shift towards older age groups, heightened public consciousness regarding health matters, elevated investment in research and development efforts, and continuous improvements in methods involving catheterization.

Anticipation surrounds the heart defect closure device sector, projecting substantial expansion in the coming years, with the market valuation slated to reach $2.12 billion by 2029, reflecting a compounded annual growth rate of 13.7%; this upward trajectory is fueled by a confluence of factors, namely the escalating prevalence of congenital anomalies, advancements in diagnostic capabilities, increased utilization of MRI scans, greater implementation of three-dimensional imaging in cardiac repair interventions, and the high incidence rates associated with ischemic strokes, while the dominant themes expected to shape this period involve continuous technological progress, the introduction of novel medical products, the creation of advanced heart closure apparatus, heightened awareness and identification of PFO closure devices, and the imperative to evaluate the merits of PFO occlusion specifically for elderly demographics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp

What Are The Drivers Pushing New Developments In The Heart Defect Closure Device Market?

An uptick in the prevalence of heart defects present from birth, identified as congenital heart problems, is anticipated to fuel the expansion of the market for devices designed to close these cardiac abnormalities. Structurally flawed hearts existing at birth encompass these congenital issues, whose rising occurrence is attributed to factors such as hereditary susceptibilities, external surroundings, and maternal health conditions like obesity, diabetes, and exposure to specific contagions or pharmaceuticals whilst pregnant. Minimally invasive remedies provided by heart defect closure implements address these conditions by mending atypical openings within the heart, thereby normalizing blood circulation, lessening subsequent issues, and enhancing the heart’s general performance; for illustration, data from a US institution specializing in biomedical informatics and computational health science research, featured in the National Library of Medicine in October 2024, showed a substantial escalation in the rate of congenital heart disease incidence, climbing to 5.46% in the year 2023, marking a notable increase from figures recorded in preceding years: 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022, consequently establishing the escalating count of individuals affected by birth defects of the heart as the primary impetus for the advancement of the heart defect closure device sector.

What Are The Primary Types Of Segments Analyzed In The Heart Defect Closure Device Market?

The heart defect closure devicemarket covered in this report is segmented –

1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices

2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials

3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices

2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices

3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders

4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders

5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders

How Are Trends Influencing The Heart Defect Closure Device Market?

Leading firms within the sphere of heart defect closure devices are focusing creation efforts on self-expanding, dual-disc occluders, intending to furnish a less invasive approach for sealing cardiac abnormalities. These self-expanding, double-disc occlusion technologies contribute to greater procedural security and yield better results for patients through quicker recuperation periods, simultaneously mitigating the potential for issues often linked with conventional open-heart operations. A prime illustration of this advancement occurred in September 2022 when Abbott Laboratories, a corporation situated in the US specializing in medical equipment and healthcare, introduced its Amplatzer Talisman PFO Occlusion System across the European market. This Amplatzer Talisman PFO Occlusion System represents a specialized medical instrument engineered to permanently close a patent foramen ovale (PFO), which is essentially an atypical connection persisting between the two upper chambers of the heart, posing risks such as cerebrovascular incidents and various other adverse effects. Through a catheter-based, minimally invasive technique, this apparatus facilitates the placement of a self-expanding occluder, constructed from a nitinol wire mesh, thus ensuring a robust seal over the PFO and thereby stopping any inter-atrial passage of harmful clots.

Who Are The Primary Competitors In The Global Heart Defect Closure Device Market?

Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, Coherex Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Which Geographies Are Emerging As Strong Markets For The Heart Defect Closure Device Industry?

North America was the largest region in the heart defect closure device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Heart Defect Closure Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16074&type=smp

Browse Through More Reports Similar to the Global Heart Defect Closure Device Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Flea Tick And Heartworm Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flea-tick-and-heartworm-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795